143 related articles for article (PubMed ID: 11526904)
41. First large-scale U.S. trial of HIV vaccine begins soon.
AIDS Policy Law; 1998 Jun; 13(12):10. PubMed ID: 11365517
[TBL] [Abstract][Full Text] [Related]
42. US puts large-scale AIDS vaccine trials on ice as 'premature'.
Macilwain C
Nature; 1994 Jun; 369(6482):593. PubMed ID: 8208274
[No Abstract] [Full Text] [Related]
43. Thailand beats the odds in completing vaccine test.
Cohen J
Science; 2003 Sep; 301(5640):1663. PubMed ID: 14500958
[No Abstract] [Full Text] [Related]
44. AIDSVAX VaxGen.
Billich A
Curr Opin Investig Drugs; 2004 Feb; 5(2):214-21. PubMed ID: 15043397
[TBL] [Abstract][Full Text] [Related]
45. Prevention of HIV: vaccine trials show only limited success.
Goldrick BA
Am J Nurs; 2003 May; 103(5):27. PubMed ID: 12762319
[No Abstract] [Full Text] [Related]
46. HIV vaccine trial results are an important step forward in developing an effective vaccine, say WHO and UNAIDS.
Rassool GH
J Adv Nurs; 2003 Jul; 43(2):116. PubMed ID: 12886893
[No Abstract] [Full Text] [Related]
47. Agouron and immune response to commercialize remune immune-based treatment.
James JS
AIDS Treat News; 1998 Jun; (No 297):1. PubMed ID: 11365593
[TBL] [Abstract][Full Text] [Related]
48. [First clinical study in Germany. Vaccination against HIV coming soon?].
Kurth R
MMW Fortschr Med; 2003 Nov; 145(46):16. PubMed ID: 14699826
[No Abstract] [Full Text] [Related]
49. First human efficacy trial of AIDS vaccine in developing country.
CVI Newswatch; 1999 May; (1):2. PubMed ID: 12295316
[TBL] [Abstract][Full Text] [Related]
50. Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults.
Pitisuttithum P; Nitayaphan S; Thongcharoen P; Khamboonruang C; Kim J; de Souza M; Chuenchitra T; Garner RP; Thapinta D; Polonis V; Ratto-Kim S; Chanbancherd P; Chiu J; Birx DL; Duliege AM; McNeil JG; Brown AE;
J Infect Dis; 2003 Jul; 188(2):219-27. PubMed ID: 12854076
[TBL] [Abstract][Full Text] [Related]
51. [Ethical elements in the development of vaccines against HIV/AIDS].
Molina CN
Sidahora; 2001 Oct; ():14-6. PubMed ID: 11776246
[No Abstract] [Full Text] [Related]
52. First AIDS vaccine tested did not protect, but gives scientific leads.
James JS
AIDS Treat News; 2003 Mar; (389):6. PubMed ID: 12712937
[TBL] [Abstract][Full Text] [Related]
53. AIDS vaccines: back to 'plan A'.
Check E
Nature; 2003 Jun; 423(6943):912-4. PubMed ID: 12827164
[No Abstract] [Full Text] [Related]
54. Vaccine trial in Thailand.
AIDS Patient Care STDS; 1999 Jun; 13(6):377. PubMed ID: 10842863
[No Abstract] [Full Text] [Related]
55. AIDS vaccine: efficacy, safety and ethics.
Veljkovic V; Veljkovic N; Glisic S; Ho MW
Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
[TBL] [Abstract][Full Text] [Related]
56. Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials.
Francis DP; Heyward WL; Popovic V; Orozco-Cronin P; Orelind K; Gee C; Hirsch A; Ippolito T; Luck A; Longhi M; Gulati V; Winslow N; Gurwith M; Sinangil F; Berman PW
AIDS; 2003 Jan; 17(2):147-56. PubMed ID: 12545073
[No Abstract] [Full Text] [Related]
57. AIDSVAX. VaxGen.
Billich A
Curr Opin Investig Drugs; 2001 Sep; 2(9):1203-8. PubMed ID: 11717805
[TBL] [Abstract][Full Text] [Related]
58. AIDSVAX results: an answer, or just more questions?
Johnston R
AIDS Patient Care STDS; 2003 Feb; 17(2):47-51. PubMed ID: 12650142
[TBL] [Abstract][Full Text] [Related]
59. Preventive HIV vaccine development in Thailand.
Nitayaphan S; Brown AE
AIDS; 1998; 12 Suppl B():S155-61. PubMed ID: 9679641
[No Abstract] [Full Text] [Related]
60. Starting from scratch: program development and lessons learned from HIV vaccine trial counseling in Thailand.
Thapinta D; Jenkins RA
Contemp Clin Trials; 2007 Jul; 28(4):409-22. PubMed ID: 17196444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
